Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Argus Health
Cerilliant
Moodys
Harvard Business School
Healthtrust
Fish and Richardson
Express Scripts
Colorcon

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,866,839

« Back to Dashboard

Summary for Patent: 6,866,839
Title: Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
Abstract:A method and composition are disclosed utilizing the pure (R,R) isomer of formoterol, which is a potent bronchodilator with reduced adverse effects, a low incidence of the development of tolerance and an increased duration of action, as compared to racemic formoterol.
Inventor(s): Aberg; Gunnar (Westborough, MA), Morley; John (Richmond-upon-Thames, GB)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:10/457,123
Patent Claim Types:
see list of patent claims
Use; Dosage form; Delivery; Composition;

Drugs Protected by US Patent 6,866,839

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,866,839

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9107196Apr 05, 1991

International Patents Family Members for US Patent 6,866,839

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
United Kingdom 9107196 ➤ Sign Up
United Kingdom 2289842 ➤ Sign Up
United Kingdom 2255503 ➤ Sign Up
United Kingdom 9517463 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Moodys
QuintilesIMS
Colorcon
Boehringer Ingelheim
UBS
McKesson
Farmers Insurance
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.